SPONSOR
Sun Yat-sen University
Total Trials
7
Recruiting
7
Phases
Phase 2, Phase 3
Conditions studied: Nasopharyngeal CarcinomaHepatocellular CarcinomaMicrowave AblationLiver CancerLenvatinibRecurrent TumorPeripheral T-Cell Lymphoma With Follicular Helper of T Cell PhenotypeValvular Heart Disease
Sun Yat-sen University is a clinical research sponsor with 7 registered studies on ClinicalTrials.gov, of which 7 are actively recruiting participants. Research covers conditions including Nasopharyngeal Carcinoma, Hepatocellular Carcinoma, Microwave Ablation, Liver Cancer.
The trial portfolio spans Phase 2, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Sun Yat-sen University
How many clinical trials has Sun Yat-sen University sponsored?
ClinicalMetric currently tracks 7 clinical trials sponsored by Sun Yat-sen University, of which 7 are actively recruiting participants. These trials cover conditions including Nasopharyngeal Carcinoma, Hepatocellular Carcinoma, Microwave Ablation. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Sun Yat-sen University research focus on?
Sun Yat-sen University clinical trials span Nasopharyngeal Carcinoma, Hepatocellular Carcinoma, Microwave Ablation, Liver Cancer, Lenvatinib, and additional conditions. The research pipeline includes Phase 2, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Sun Yat-sen University clinical trial?
To participate in a Sun Yat-sen University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Sun Yat-sen University trials with current recruitment status updated daily.
Clinical Trials by Sun Yat-sen University
NCT05447169
Recruiting
Epstein-Barr Virus Antibody and Epstein-Barr Virus DNA for Nasopharyngeal Carcinoma Screening
Nasopharyngeal Carcinoma
NCT05444478
Recruiting
Microwave Ablation Simultaneously Combined With Lenavatinib for Recurrent Hepatocellular Carcinoma
Hepatocellular Carcinoma
NCT06031285 Phase 2
Recruiting
Perioperative Sintilimab Plus Bevacizumab Biosimilar and TACE-HAIC for HCC Patients With PVTT: A Phase-2 Clinical Trial
Hepatocellular Carcinoma
NCT06170021
Recruiting
Occurrence of Radiation-induced Otitis Media in Nasopharyngeal Carcinoma Patients After Intensity Modulated Radiotherapy
Nasopharyngeal Carcinoma
NCT05572983 Phase 2
Recruiting
Phase Ⅱ Study of Chidamide in Combination With CHOP in Previously Untreated Peripheral T-Cell Lymphoma With Follicular Helper of T Cell Phenotype
Peripheral T-Cell Lymphoma With Follicular Helper of T Cell Phenotype
NCT07065500
Recruiting
Mechanism and Effect of Novel Metabolites on Valvular Heart Disease
Valvular Heart Disease
NCT05476432 Phase 3
Recruiting
HAIC With One-day FOLFOX vs. HAIC With Two-day FOLFOX for Unresectable HCC: a Non-inferiority Study
Hepatocellular Carcinoma
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology